Elanco Animal Health Incorporated (ELAN)

USD 8.34

(2.96%)

Long Term Debt Summary of Elanco Animal Health Incorporated

Elanco Animal Health Incorporated's latest annual long term debt in 2023 was 5.73 Billion USD , up 5.29% from previous year.
Elanco Animal Health Incorporated's latest quarterly long term debt in 2024 Q2 was 5.46 Billion USD , down -4.61% from previous quarter.
Elanco Animal Health Incorporated reported annual long term debt of 5.44 Billion USD in 2022, down -9.58% from previous year.
Elanco Animal Health Incorporated reported annual long term debt of 6.02 Billion USD in 2021, up 8.12% from previous year.
Elanco Animal Health Incorporated reported quarterly long term debt of 5.46 Billion USD for 2024 Q2, down -4.61% from previous quarter.
Elanco Animal Health Incorporated reported quarterly long term debt of 5.73 Billion USD for 2023 FY, up 5.29% from previous quarter.

Annual Long Term Debt Chart of Elanco Animal Health Incorporated (2023 - 2016)

Historical Annual Long Term Debt of Elanco Animal Health Incorporated (2023 - 2016)

Year	Long Term Debt	Long Term Debt Growth
2023	5.73 Billion USD	5.29%
2022	5.44 Billion USD	-9.58%
2021	6.02 Billion USD	8.12%
2020	5.57 Billion USD	139.11%
2019	2.33 Billion USD	-4.62%
2018	2.44 Billion USD	0.0%
2017	- USD	0.0%
2016	- USD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q1	5.72 Billion USD	-0.16%
2024 Q2	5.46 Billion USD	-4.61%
2023 FY	5.73 Billion USD	5.29%
2023 Q1	5.63 Billion USD	3.51%
2023 Q2	6.02 Billion USD	6.81%
2023 Q3	5.87 Billion USD	-2.54%
2023 Q4	5.73 Billion USD	-2.28%
2022 Q2	6 Billion USD	-1.09%
2022 FY	5.44 Billion USD	-9.58%
2022 Q4	5.44 Billion USD	-1.07%
2022 Q3	5.5 Billion USD	-8.32%
2022 Q1	6.07 Billion USD	0.8%
2021 Q2	5.54 Billion USD	-0.25%
2021 Q3	6.27 Billion USD	13.19%
2021 FY	6.02 Billion USD	8.12%
2021 Q4	6.02 Billion USD	-3.95%
2021 Q1	5.55 Billion USD	-0.29%
2020 Q1	2.03 Billion USD	-12.65%
2020 Q2	2.03 Billion USD	-0.26%
2020 Q3	5.58 Billion USD	175.14%
2020 FY	5.57 Billion USD	139.11%
2020 Q4	5.57 Billion USD	-0.25%
2019 Q4	2.33 Billion USD	-0.22%
2019 Q1	2.43 Billion USD	-0.27%
2019 Q3	2.33 Billion USD	-1.95%
2019 FY	2.33 Billion USD	-4.62%
2019 Q2	2.38 Billion USD	-2.24%
2018 Q1	- USD	0.0%
2018 FY	2.44 Billion USD	0.0%
2018 Q4	2.44 Billion USD	-1.42%
2018 Q3	2.47 Billion USD	0.0%
2018 Q2	- USD	0.0%
2017 Q1	- USD	0.0%
2017 Q4	- USD	0.0%
2017 FY	- USD	0.0%
2016 FY	- USD	0.0%

Peer Long Term Debt Comparison of Elanco Animal Health Incorporated

Name	Long Term Debt	Long Term Debt Difference
Amneal Pharmaceuticals, Inc.	2.52 Billion USD	-127.357%
Bausch Health Companies Inc.	21.93 Billion USD	73.854%
Catalent, Inc.	4.54 Billion USD	-26.205%
Emergent BioSolutions Inc.	446.5 Million USD	-1184.658%
Perrigo Company plc	3.63 Billion USD	-57.895%
Teva Pharmaceutical Industries Limited	18.48 Billion USD	68.963%
Zoetis Inc.	6.56 Billion USD	12.614%